TipRanks
Moleculin Biotech (DE:MOL0)
FRANKFURT:MOL0
Germany Market
MOL0
Moleculin Biotech
RESEARCH TOOLSreports

Moleculin Biotech (MOL0) Income Statement

3 Followers

Moleculin Biotech Income Statement

Last quarter (Q2 2026), Moleculin Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Moleculin Biotech's net income was $-7.63M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -90.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 25.10M$ 26.64M$ 29.63M$ 30.64M$ 22.97M
Depreciation and Amortization
$ 90.00K$ 126.00K$ 127.00K$ 130.00K$ 164.00K
EBITDA
$ -33.47M$ -21.64M$ -29.64M$ -28.89M$ -15.73M
Operating Income
$ -25.10M$ -26.64M$ -29.63M$ -30.64M$ -22.97M
Other Income/Expenses
$ -8.46M$ 4.88M$ -138.00K$ 1.61M$ 7.07M
Pretax Income
$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Net Income
$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Per Share Metrics
Basic EPS
$ -28.42$ -189.14$ -376.71$ -380.51$ -221.77
Diluted EPS
$ -28.42$ -189.14$ -376.71$ -380.51$ -221.77
Weighted Average Shares Outstanding
 1.18M 137.72K 79.02K 76.28K 71.67K
Weighted Average Shares Outstanding (Diluted)
 1.18M 137.72K 79.02K 76.28K 71.67K
Currency in USD

Moleculin Biotech Earnings and Revenue History